Aptiv Solutions is banking on its expertise in areas such as adaptive clinical trials and software development to differentiate the Reston, VA-based CRO. Today, the company outlined its new organizational structure, which combines multiple business units.
A firm called ADDPLAN, a maker of adaptive clinical trials software, is among the units of the new company. Aptiv says it has also merged the resources and expertise of Averion International, ClinResearch and Fulcrum Pharma. Its subsidiaries include Trio Clinical Resourcing, a staffing and outsourcing outfit, and Niphix, a Japanese CRO specializing in oncology.
This news follows an announcement in April that Aptiv's new senior team would include Gernot Wassmer, a co-founder of ADDPLAN, who will be leading further development of the firm's adaptive clinical trials software. At the same time, Vladimir Dragalin--an adaptive clinical design specialist with experience at Quintiles, GSK, Pfizer and Wyeth--was listed as the senior vice president of software development and consulting at Aptiv.
Aptiv Chairman and CEO Patrick Donnelly said: "As of today, Aptiv Solutions is the only CRO to offer design, simulation and execution of adaptive clinical trials--and the only partner to make fully functional adaptive trials a reality. Our focus in adaptive clinical trials is central to our mission of developing unique, comprehensive solutions for the future."
Donnelly happens to be the former CEO and a co-founder of PRA International, a CRO which last month boosted its technology offerings with its acquisition of clinical trials software developer Kinship Technologies in Chennai, India. Clearly, his new firm isn't the only clinical research organization that aims to enhance its services with internal expertise in software development.
- here's the Aptiv release